1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Yang L, Parkin DM, Ferlay J, Li L and Chen
Y: Estimates of cancer incidence in China for 2000 and projections
for 2005. Cancer Epidemiol Biomarkers Prev. 14:243–250.
2005.PubMed/NCBI
|
3
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Dickinson LA, Joh T, Kohwi Y and
Kohwi-Shigematsu T: A tissue-specific MAR/SAR DNA-binding protein
with unusual binding site recognition. Cell. 70:631–645. 1992.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Alvarez JD, Yasui DH, Niida H, Joh T, Loh
DY and Kohwi-Shigematsu T: The MAR-binding protein SATB1
orchestrates temporal and spatial expression of multiple genes
during T-cell development. Genes Dev. 14:521–535. 2000.PubMed/NCBI
|
6
|
Fessing MY, Mardaryev AN, Gdula MR, Sharov
AA, Sharova TY, Rapisarda V, Gordon KB, Smorodchenko AD,
Poterlowicz K, Ferone G, et al: p63 regulates Satb1 to control
tissue-specific chromatin remodeling during development of the
epidermis. J Cell Biol. 194:825–839. 2011. View Article : Google Scholar : PubMed/NCBI
|
7
|
Kohwi-Shigematsu T, Poterlowicz K,
Ordinario E, Han HJ, Botchkarev VA and Kohwi Y: Genome organizing
function of SATB1 in tumor progression. Semin Cancer Biol.
23:72–79. 2013. View Article : Google Scholar : PubMed/NCBI
|
8
|
Cai S, Han HJ and Kohwi-Shigematsu T:
Tissue-specific nuclear architecture and gene expression regulated
by SATB1. Nat Genet. 34:42–51. 2003. View
Article : Google Scholar : PubMed/NCBI
|
9
|
Zhao XD, Ji WY, Zhang W, He LX, Yang J,
Liang HJ and Wang LL: Overexpression of SATB1 in laryngeal squamous
cell carcinoma. ORL J Otorhinolaryngol Relat Spec. 72:1–5. 2010.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Mokhtar NM, Ramzi NH, Yin-Ling W, Rose IM,
Hatta Mohd Dali AZ and Jamal R: Laser capture microdissection with
genome-wide expression profiling displayed gene expression
signatures in endometrioid endometrial cancer. Cancer Invest.
30:156–164. 2012. View Article : Google Scholar : PubMed/NCBI
|
11
|
Tu W, Luo M, Wang Z, Yan W, Xia Y, Deng H,
He J, Han P and Tian D: Upregulation of SATB1 promotes tumor growth
and metastasis in liver cancer. Liver Int. 32:1064–1078. 2012.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Meng WJ, Yan H, Zhou B, Zhang W, Kong XH,
Wang R, Zhan L, Li Y, Zhou ZG and Sun XF: Correlation of SATB1
overexpression with the progression of human rectal cancer. Int J
Colorectal Dis. 27:143–150. 2012. View Article : Google Scholar : PubMed/NCBI
|
13
|
Chen H, Takahara M, Oba J, Xie L, Chiba T,
Takeuchi S, Tu Y, Nakahara T, Uchi H, Moroi Y and Furue M:
Clinicopathologic and prognostic significance of SATB1 in cutaneous
malignant melanoma. J Dermatol Sci. 64:39–44. 2011. View Article : Google Scholar : PubMed/NCBI
|
14
|
Cheng C, Lu X, Wang G, Zheng L, Shu X, Zhu
S, Liu K, Wu K and Tong Q: Expression of SATB1 and heparanase in
gastric cancer and its relationship to clinicopathologic features.
APMIS. 118:855–863. 2010. View Article : Google Scholar : PubMed/NCBI
|
15
|
Lu X, Cheng C, Zhu S, Yang Y, Zheng L,
Wang G, Shu X, Wu K, Liu K and Tong Q: SATB1 is an independent
prognostic marker for gastric cancer in a Chinese population. Oncol
Rep. 24:981–987. 2010.PubMed/NCBI
|
16
|
Mao L, Yang C, Wang J, Li W, Wen R, Chen J
and Zheng J: SATB1 is overexpressed in metastatic prostate cancer
and promotes prostate cancer cell growth and invasion. J Transl
Med. 11:1112013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Zhou LY, Liu F, Tong J, Chen QQ and Zhang
FW: Expression of special AT-rich sequence-binding protein mRNA and
its clinicopathological significance in non-small cell lung cancer.
Nan Fang Yi Ke Da Xue Xue Bao. 29:534–537. 2009.(In Chinese).
PubMed/NCBI
|
18
|
Selinger CI, Cooper WA, Al-Sohaily S,
Mladenova DN, Pangon L, Kennedy CW, McCaughan BC, Stirzaker C and
Kohonen-Corish MR: Loss of special AT-rich binding protein 1
expression is a marker of poor survival in lung cancer. J Thorac
Oncol. 6:1179–1189. 2011. View Article : Google Scholar : PubMed/NCBI
|
19
|
Zhang S, Gao X, Ma Y, Jiang J, Dai Z, Yin
X, Min W, Hui W and Wang B: Expression and significance of SATB1 in
the development of breast cancer. Genet Mol Res. 14:3309–3317.
2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Hedner C, Gaber A, Korkocic D, Nodin B,
Uhlén M, Kuteeva E, Johannesson H, Jirström K and Eberhard J: SATB1
is an independent prognostic factor in radically resected upper
gastrointestinal tract adenocarcinoma. Virchows Arch. 465:649–659.
2014. View Article : Google Scholar : PubMed/NCBI
|
21
|
Rice TW, Blackstone EH and Rusch VW: 7th
Edition of the AJCC cancer staging manual: Esophagus and
esophagogastric junction. Ann Surg Oncol. 17:1721–1724. 2010.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Wan F, Cheng C, Wang Z, Xiao X, Zeng H,
Xing S, Chen X, Wang J, Li S, Zhang Y, et al: SATB1 overexpression
regulates the development and progression in bladder cancer through
EMT. PLoS One. 10:e01175182015. View Article : Google Scholar : PubMed/NCBI
|
24
|
Han HJ, Russo J, Kohwi Y and
Kohwi-Shigematsu T: SATB1 reprogrammes gene expression to promote
breast tumour growth and metastasis. Nature. 452:187–193. 2008.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Cong QX, Zhang H, Sun SX, Li HF, Wang Y
and Jian S: Pilot study special AT-rich sequence-binding protein 1
investigating as a potential biomarker for esophageal squamous cell
carcinoma. Dis Esophagus. 29:621–626. 2016. View Article : Google Scholar : PubMed/NCBI
|
26
|
Tesone AJ, Rutkowski MR, Brencicova E,
Svoronos N, Perales-Puchalt A, Stephen TL, Allegrezza MJ, Payne KK,
Nguyen JM, Wickramasinghe J, et al: Satb1 overexpression drives
tumor-promoting activities in cancer-associated dendritic cells.
Cell Rep. 14:1774–1786. 2016. View Article : Google Scholar : PubMed/NCBI
|
27
|
Borghesi L: Hematopoiesis in steady-state
versus stress: Self-renewal, lineage fate choice, and the
conversion of danger signals into cytokine signals in hematopoietic
stem cells. J Immunol. 193:2053–2058. 2014. View Article : Google Scholar : PubMed/NCBI
|
28
|
Song Y, Wang Y, Xu L, Ma J, Chen E, Zang
R, Jia W, Tao X and Hu L: A genetic variant in CHRNB3-CHRNA6
increases risk of esophageal squamous cell carcinoma in Chinese
populations. Carcinogenesis. 36:538–542. 2015. View Article : Google Scholar : PubMed/NCBI
|
29
|
Chen J, Kwong DL, Cao T, Hu Q, Zhang L,
Ming X, Chen J, Fu L and Guan X: Esophageal squamous cell carcinoma
(ESCC): Advance in genomics and molecular genetics. Dis Esophagus.
28:84–89. 2015. View Article : Google Scholar : PubMed/NCBI
|
30
|
Morita M, Kumashiro R, Kubo N, Nakashima
Y, Yoshida R, Yoshinaga K, Saeki H, Emi Y, Kakeji Y, Sakaguchi Y,
et al: Alcohol drinking, cigarette smoking, and the development of
squamous cell carcinoma of the esophagus: Epidemiology, clinical
findings, and prevention. Int J Clin Oncol. 15:126–134. 2010.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Kasagi Y, Morita M, Otsu H, Kawano H, Ando
K, Hiyoshi Y, Ito S, Miyamoto Y, Saeki H, Oki E and Maehara Y:
Clinicopathological characteristics of esophageal squamous cell
carcinoma in patients younger than 50 years. Ann Surg Oncol.
22:311–315. 2015. View Article : Google Scholar : PubMed/NCBI
|
32
|
Wu IC, Wu CC, Lu CY, Hsu WH, Wu MC, Lee
JY, Chou SH, Lee JM, Chou YP, Wu DC and Wu MT: Substance use
(alcohol, areca nut and cigarette) is associated with poor
prognosis of esophageal squamous cell carcinoma. PLoS One.
8:e558342013. View Article : Google Scholar : PubMed/NCBI
|